Sellas Life Sciences Group Inc (SLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,990 | -18,380 | -14,370 | -10,990 | N/A |
| Depreciation Amortization | 170 | 160 | 330 | 30 | N/A |
| Other Working Capital | -2,730 | 1,140 | -5 | 670 | N/A |
| Other Operating Activity | 4,300 | 5,320 | 4,625 | 4,250 | 0 |
| Operating Cash Flow | $-10,250 | $-11,760 | $-9,420 | $-6,040 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -100 | 0 | -160 | -220 | N/A |
| Other Investing Activity | 0 | -80 | 9,760 | -9,800 | 0 |
| Investing Cash Flow | $-100 | $-80 | $9,600 | $-10,020 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 11,570 | 7,680 | 7,920 | 17,830 | 0 |
| Financing Cash Flow | $11,570 | $7,680 | $7,920 | $17,830 | $N/A |
| Beginning Cash Position | 5,680 | 9,850 | 1,760 | 2 | N/A |
| End Cash Position | 6,890 | 5,680 | 9,850 | 1,760 | N/A |
| Net Cash Flow | $1,200 | $-4,170 | $8,090 | $1,760 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,250 | -11,760 | -9,420 | -6,040 | N/A |
| Free Cash Flow | -10,250 | -11,760 | -9,420 | -6,040 | 0 |